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Endotoxic lipopolysaccharide (LPS) molecules from Gram-negative bacteria consist of a polysaccha- 
ride and lipid moiety. This lipid has been found to be responsible for most of the endotoxic reactions, 
including B-cell mitogenesis (1-3). 
The  chemical structure of the lipid  moiety was studied by analyzing "Lipid A"  preparations 
obtained  from  LPS  (1,  4),  followed  by  structural  investigation  of  the  endotoxic  glycolipid  of 
Salmonella  minnesota R595 which consists of lipid and 2-keto-3-deoxyoctonate  (KDO) only, without 
the polysaccharide. These studies led to the discovery of a  new class of glycolipids in which the 
long-chain carboxylic acids  are  esterified or amide-bound to  D-glucosamine phosphates (4).  The 
findings have been confirmed by several laboratories (5, 6). 
Accordingly,  two  of  us  (Asselineau  and Nowotny)  synthesized model  compounds similar  in 
structure  to  some  components of Lipid  A,  by  esterifying various  amino sugars with  long-chain 
carboxylic acids, or by substituting one H of the primary amino group with various fatty acids in an 
amide-type linkage. In this report we present evidence that a simple synthetic glycolipid N-palmitoyl 
D-glucosamine (NPG) is mitogenic for mouse B lymphocytes. 
Materials and Methods 
Animals.  Normal 6-8-wk old female C57BI/6J  (Jackson Laboratories, Bar Harbor,  Maine) or 
C3H/HEN,  or  nu/nu  mice  (Division  of  Research  Services,  NIH)  were  used  for  the  mitogen 
experiments. Cells from these three strains respond well to endotoxin in vitro. 
Reagents  and  Media.  RPMI  1640 (Grand  Island  Biological  Co.,  Grand  Island,  N.  Y.)  was 
supplemented with  glutamine  (2  mM/m[),  penicillin (100 ttg/ml), and streptomycin (100 ug/ml). 
Hepes  buffer  was  titrated  to  pH  7.2  with  NaOH  and  added  to  the  media  to  produce a  final 
concentration of 15 mM. Concanavalin A (Con A) (2  ×  crystallized) (Nutritional Biochemical Corp., 
Cleveland, Ohio) was used at  a  final concentration of 1 #g/ml in culture and phytohemagglutinin 
(Wellcome Research Laboratories, Beckenham, England) at 2 ttg/ml. LPS from S. minnesota and the 
natural  glycolipid from the rough  mutant  of S.  minnesota  R595  were obtained and prepared as 
previously described (7). 
Synthesis  of NPG.  N-palmitoyl-D-glucosamine (NPG)  was  synthesized by  the  procedure of 
Fieser and associates (8).  The NPG was recrystallized twice from petroleum ether-benzene =  1:1, 
m.p.  198-202°C.  The  product was homogeneous in thin-layer chromatography using chloroform: 
methanol:water -  140:35:4. 
Solubilization  for Biological Assays.  Both synthetic NPG and the natural glycolipid R595 were 
insoluble in water. Therefore, in order to use them in culture they were first suspended in pyrogen-free 
distilled water at a  concentration of 1 mg/ml and then sonicated for 1 min at  1.7 amp.  (Branson 
Instruments Co., Stamford, Conn.). They were then sterilized by boiling for 30 min. After heating, the 
synthetic glycolipid formed a  precipitate, therefore it was redispersed by sonication for 1 min, and 
made isotonic with appropriate amounts of sterile, pyrogen-free 9% NaCl. The natural glycolipid was 
treated  in  a  similar  fashion,  but  without  heating.  Two  fatty  acids,  palmitic  and  myristic acid 
(Applied Science Laboratories, State College, Pa.), and glucosamine .HC1 (Sigma Chemical Co., St. 
Louis, Mo.) were treated in exactly the same fashion as the synthetic glycolipid and used as controls. 
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Cell Collection and Tissue Culture.  Spleens were removed aseptically and single cell suspensions 
were prepared by rinsing the cells from the splenic capsule with medium from a needle and a syringe. 
The spleen cells were washed twice and suspended at  a  concentration of 2  ×  10 e cells per ml  in 
medium supplemented with 2% FCS (Industrial Biological Laboratories, Rockville, Md.). Triplicate 
0.2-ml  samples were cultured  along with the test  materials  in  round bottom, plastic microtrays 
(Cooke Engineering Co., Alexandria, Va.) for 72 h at 37°C, in a humidified atmosphere of 5% CO, in 
air and then pulsed with 0.5 #Ci of tritiated thymidine ([SH]Tdr, 6.0 Ci/mM, Schwarz/Mann Div., 
Becton, Dickinson & Co., Orangeburg, N.Y.) for the last 4 h of culture. Cultures were harvested using 
a  multiple automated harvesting apparatus (Mash II,  Microbiological Associates, Inc., Bethesda, 
Md.) and counted in a Packard Tri-Carb Scintillation Counter (Packard Instrument Co., Downers 
Grove, Ill.). The geometric mean of the counts per minute (cpm) of triplicate samples was determined 
and the results expressed as the stimulation ratio (E/C), where E/C is defined as the ratio of mean 
cpm in the experimental cultures divided by the mean cpm in the control (unstimulated) cultures. 
Limulus Lysate Clotting Assay.  The Limulus assay was carried out by the procedure of Levin et 
al.  under pyrogen-free conditions (9).  All glass or metal instruments were heated at  180°C  for 3 h 
before the  experiments. The  mitogenic  NPG  preparation  never  caused  gel  formation but  at  a 
concentration of 100  #g/ml  did  produce  an  incomplete (viscous)  reaction.  In  contrast,  the  LPS 
preparation produced a viscous change at 0.001 #g/ml. 
Results 
Effect of the Physical State of NPG on its Mitogenic Activity.  In preliminary 
experiments we found that the synthetic glycolipid was mitogenic only after an 
initial  treatment  of  heating  and  resonication.  In  order  to  determine  the 
importance of the physical state on mitogenic activity, purified NPG was treated 
with  heating or sonication in a  sequential fashion and  its  mitogenic ability at 
each  state  determined.  Each  preparation  was  tested  over  a  wide  range  of 
concentrations  (0.01-100  ttg/ml)  and  the  maximum  proliferative response  in- 
duced reported in Table I. 
When NPG was sonicated it formed a  turbid suspension which, when tested, 
was  only weakly mitogenic (E/C  =  3.0). After heating (100°C  ×  30  min.),  the 
NPG formed dense aggregates that no longer remained in suspension and in this 
form, it was  also a  poor mitogen (E/C  =  2.4). However, when this preparation 
was resonicated (1 min, 4°C, 1.7 amp.) it again formed a turbid suspension which 
was now a  potent mitogen (E/C  =  26.0). Interestingly, prolonged sonication (5 
TABLE I 
Effect of Physical State on the Mitogenic Activity of the 
N-Pahnitoyl-D-Glucosamine 
Compound  Treatment 
Maximum 
lymphocyte 
proliferative 
response (E/C) 
NPG  Mild sonication 
Heated 
Heated and mild re- 
sonication 
Heated and prolonged 
sonication 
3.1±0.9 
2.3±0.6 
26.0±4.2 
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min,  25°C,  1.7  amp)  reduced rather than increased the  mitogenic activity of 
NPG. 
Several different preparations of NPG were tested and they uniformly required 
heating  and  son±cation  to  render  them  mitogenic.  The  explanation  of  this 
phenomenon is presently unclear. However, two points are important. First, the 
fact that unheated NPG is not mitogenic is evidence that this compound is not 
contaminated by endotoxin. Secondly, the NPG glycolipid by itself must be in a 
proper state of dispersion to activate a B lymphocyte. 
Mitogenic Activity  of Synthetic  Glycolipid on Spleen  Cells [rom Normal and 
nu/nu Mice.  Spleen cells from normal mice were cultured in the presence of a 
broad  dose  range  of the  synthetic glycolipid  and  their  maximum  mitogenic 
response determined (Table II). NPG produced approximately one-half as much 
TABLE II 
Mitogenic Activities of Various Preparations on Spleen Cells [rom 
Normal and nu/nu Mice 
Stimulant 
Maximum lymphocyte proliferative 
response (E/C)* 
Normal  nu/nu 
Con A  562.9 ±  13.2  2.8 ±  0.4 
PHA  147.1 ±  17.7  0.9 ±  0.1 
LPS  28.3 ~  4.1  66.7 ±  3.8 
Natural Glycolipid  from S.  42.1 ±  7.7  58.7 ±  3.7 
minnesota R595 
Crude synthetic NPG  6.8 ±  1.2  22.8 ±  1.2 
Recrystallized  NPG  14.2 ±  4.2  41.0 ±  2.1 
Myristic acid  1.0 ± 0.1  1.3 ±  0.2 
Palm±tic acid  1.2 ± 0.2  1.1  ±  0.2 
Giucosamine  1.0 ±  0.05  1.1  ±  0.05 
* Results  represent  the  arithmetic  means  ±  SEM  of  three  separate 
experiments. The  mean baseline proliferation of 2  ×  105 normal spleen 
cells was 190.7 cpm and Nu/Nu spleen cells was 104.0 cpm. 
stimulation  as  did  LPS  and  about  one-third  as  much  as  did  the  natural 
glycolipid, R595.  Nevertheless, it is clear that the synthetic glycolipid possessed 
significant  mitogenic  activity.  Furthermore,  it  is  interesting  to  note  that 
purification of NPG, which removes unreacted glucosamine, palm±tic acid, and 
other  contaminating substances,  doubled the  mitogenic activity of this  com- 
pound. 
In order to determine if this compound was a  B-lymphocyte mitogen, it was 
tested on spleen cells from athymic, nu/nu mice. As expected, nu/nu spleen cells 
responded poorly or not at all to the T-lymphocyte mitogens, Con A, and PHA 
but had an enhanced response to the B-cell mitogens, LPS, and S.  minnesota 
R595 glycolipid. Likewise, the response to the synthetic glycolipid NPG was also 
significantly increased. Neither palm±tic nor myristic acids, nor glucosamine by 
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The dose response of the NPG preparations in comparison with that of LPS is 
presented in Fig. 1. Recrystallized NPG was already mitogenic at a concentration 
of 0.01  ug/ml, and its mitogenic activity increased up to a  concentration of 10 
ug/ml,  but  fell off rapidly  at  a  concentration of  100  ug/ml.  In  contrast,  the 
unpurified (crude) NPG only began to exhibit mitogenic activity at 1 ug/ml and 
the response continued to increase to a  maximum at 100 ~g/ml. In comparison, 
LPS  was  a  better  mitogen  at  every  concentration tested  but  the  measured 
difference between the dose response curves of LPS and NPG was such that there 
would have had to have been at least a 10% contamination of the purified NPG 
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Fro.  1.  Mitogenic activity of LPS and synthetic glycolipid on mouse spleen cells. Unpurified 
(crude)  or  purified  (recrystallized)  N-palmitoyl-D-glucosamine (NPDG)  was  assayed  for 
mitogenic activity on mouse spleen cells in comparison to S. minnesota LPS. The results are 
the arithmetic mean of the stimulation ratios of three experiments ±  1 SEM. 
with endotoxin to account for the mitogenic activity of this synthetic compound. 
Since this degree of endotoxin contamination was virtually eliminated by the 
Limulus lysate assay, these data demonstrate that the synthetic NPG itself is 
mitogenic. 
Discussion 
A major consideration in any study of this kind is whether the compounds being 
tested are contaminated with other naturally occurring B-cell mitogens such as 
endotoxin.  It  is  extremely  unlikely  that  there  is  any  significant  endotoxin 
contamination of our  synthetic  preparations  for  several  reasons.  First,  these 1408  ROSENSTREICH  ET  AL.  BRIEF  DEFINITIVE  REPORT 
preparations  by themselves  are  nonmitogenic unless heat,  ed  and  resonicated, 
which is not a requirement for endotoxin to be mitogenic. Secondly, purification 
of these  compounds  by  recrystallization from  organic  solvents  which  would 
remove any endotoxin, if present, increases rather than decreases the mitogenic 
activity, and furthermore, this preparation of NPG is homogeneous by thin-layer 
chromatography. Finally, by using the sensitive Limulus lysate assay that tests 
for the presence of endotoxin, we have determined that there could be no greater 
than 0.001% endotoxin in  our glycolipid preparations,  which is not enough to 
account for their mitogenic activity. 
According to  the  reported  observations,  NPG  requires  a  certain  degree  of 
dispersion to be mitogenic. All previously described B-cell mitogens or thymic- 
independent antigens such  as  LPS (3), polymerized flagellin (10), and poly I: 
poly  C  (11) are  high  molecular weight,  polymeric  compounds with  multiple 
repeating determinants. In contrast, NPG is a low molecular weight compound 
(mol wt, 412),  but it does form polymers of different and indeterminate sizes in 
aqueous solutions. Thus, it is possible that one effect of heating and sonication of 
NPG is to form micelles with oriented structures, of such a size or orientation 
that they are in effect polymeric structures with multiple repeating units that 
thereby act as B-cell mitogens. However, at present we do not know the exact 
physical state of the NPG in either the mitogenic or nonmitogenic forms. Studies 
are currently underway in these laboratories to answer this question, including 
particle  size  determination  of  active  NPG  dispersions  by  light-scattering 
photometry and by electron microscopy. 
The  demonstration  of  mitogenic  activity  in  a  simple,  entirely  synthetic 
glycolipid may be of fundamental importance in furthering our understanding of 
the mechanism of activation by both endotoxin and other B-cell mitogens. There 
are  several  tentative  conclusions  that  we  can  make  on  the  basis  of  the 
observation.  First,  it  is  clear  that  only a  small  component  of the  endotoxin 
molecule actually carries  the  mitogenic signal. However, the remainder of the 
molecule may be important in both maintaining solubility and possibly orienting 
the glycolipid or exposing the glycolipid in such a way so that it interacts with the 
cell membrane. Furthermore, these data suggest that the nature of the mitogenic 
signal of LPS most probably is a  specific physicochemical interaction between 
the lipophilic moiety of LPS and the lipid fraction of the cell membrane. 
Previous  findings  from  our  laboratories  indicate  that  not  all  endotoxic 
properties  are  dependent  on  a  single  structural  property or  on  one  chemical 
functional group in the endotoxin macromolecule (12). The ability to synthesize 
compounds with  endotoxin-like properties  raises  the  possibility that  different 
compounds can  be  synthesized with other specific endotoxin-like activities in 
addition to mitogenicity. Thus, using this approach it may at last be possible to 
correlate a specific chemical structure with a specific biological activity. 
Summary 
A  synthetic glycolipid, N-palmitoyl-D-glucosamine, (NPG)  was found to be  a 
potent B-cell mitogen, that stimulated spleen cells from nu/nu as well as from 
normal mice. The proper dispersion of the water insoluble preparation is critical ROSENSTREICH ET AL.  BRIEF  DEFINITIVE REPORT  1409 
for the elicitation of this mitogenic effect. Limulus lysate clotting assay indicated 
that the NPG preparation either contains only 0.001% endotoxin contamination, 
or that NPG itself is 10  5 times less active in this assay than purified endotoxic 
LPS.  Since  such  low levels  of endotoxin concentration are  not  mitogenic,  it  is 
concluded that synthetic N-palmitoyl-D-glucosamine, when properly dispersed, 
is itself a  B-cell mitogen. 
We would like to thank Ms. Lynda Weedon  for her invaluable technical assistance in this project, and 
Dr. Chungming Chang, Temple University for performing the Limulus lysate assay. 
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